Tirzepatide in Boca Raton, FL
For adults in Boca Raton researching weight management options, Tirzepatide is the active pharmaceutical ingredient in the FDA-approved products Mounjaro / Zepbound, which were studied in trials supporting their FDA approvals. With Florida reporting an obesity rate of 32.4% and diabetes affecting 12.1% of the population, demand for medically supervised GLP-1 care in the Southeast continues to grow. Weight Method's separate program prescribes compounded Tirzepatide (dispensed by U.S.-licensed 503A pharmacies and not FDA-approved) to Boca Raton residents through telehealth — no clinic visit required.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
GLP-1 weight-loss treatment available to eligible patients in Boca Raton, FL. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
How does this medication work for weight loss?
For many people in Boca Raton, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide (Mounjaro / Zepbound) addresses the hormonal drivers of excess weight, helping your body regulate appetite at the source. Weight Method's telehealth program brings this treatment to Florida residents with a streamlined process: complete an online assessment, consult with a licensed provider, and receive your Tirzepatide shipped directly to your Boca Raton address. Average weight loss in clinical trials is 20-25% of body weight of body weight over 12-18 months.
What treatment options are available locally?
Research confirms that Tirzepatide is effective across all ethnic groups, but outcomes improve when care is culturally informed. In Boca Raton, Weight Method pairs Tirzepatide treatment with bilingual support that respects the cultural context of our patients — from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with.
Your Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

